Form 8-K CORCEPT THERAPEUTICS For: Jan 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Corcept Therapeutics (CORT) Tops Q4 EPS by 3c; Issues Light FY16 Revenue Outlook
January 28, 2016 4:15 PM ESTCorcept Therapeutics (NASDAQ: CORT) reported Q4 EPS of $0.01, $0.03 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $15 million versus the consensus estimate of $15.5 million.
GUIDANCE:
Corcept Therapeutics sees FY2016 revenue of $76-81 million, versus the consensus of... More
